预测与华法林相关的出血的新型血图:回顾性队列研究
1Department of Cardiology, The Seventh People's Hospital of Zhengzhou, Zhengzhou, China.
概括
这项研究开发了一种新型血谱,用于预测心脏病患者的华法林相关出血风险. 该模型确定了关键的风险因素,使得个性化治疗和更好的患者管理抗凝固药治疗.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 医疗信息学 医疗信息学
背景情况:
- 华法林是一种重要的抗凝剂,但出血并发症经常导致治疗中止.
- 对于与华法林相关的出血,现有的风险预测模型是不够的,这凸显了需要改进工具的需要.
研究的目的:
- 在服用华法林的患者中开发和验证重大和临床相关非重大 (CRNM) 出血的新型风险预测名录.
主要方法:
- 一组280名心脏病门诊患者接受华法林治疗的队列被跟踪了一年.
- 最小绝对收缩和选择运算符 (LASSO) 回归确定了预测因素,后向逐步选择完善了模型.
- 用ROC曲线,校准图,Hosmer-Lemeshow测试和决策曲线分析 (DCA) 来评估模型性能.
主要成果:
- 最终的诺莫图包括四个预测因素:女性性别,过时性缺血性发作 (TIA),治疗范围内的时间 (TTR) 和贫血.
- 该模型显示了可接受的歧视 (AUC = 0.68) 和优异的性能,与九个现有的评分系统相比.
- 命名图显示了良好的校准和临床实用性,这得到了DCA的证实.
结论:
- 已经开发了一种经过验证的血谱,用于预测与华法林相关的出血风险.
- 该工具促进了快速风险分层,并支持华法林使用者的个性化治疗策略.
- 血谱为管理抗凝药疗法和减轻出血并发症提供了宝贵的基础.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
697
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
697
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
01:24Disorders of Hemostasis
906
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
906